Experts have begun the first immunotherapy clinical trial in Nigeria to treat colorectal cancer, saying the treatment offers new hope to patients battling an advanced stage of the disease. They said the trial, which is one of the first in sub-Saharan Africa, would see doctors using immunotherapy, a treatment that harnesses the body’s own immune system, to treat patients with colorectal cancer free of charge. The team of experts is drawn from Medserve, Obafemi Awolowo University, and Lagos University Teaching Hospital in Nigeria, working collaboratively with Memorial Sloan Kettering Cancer Center, a world leader in cancer care based in the United States. The study, titled “PD-1 Blockade in Mismatch-Repair Deficient Colorectal Cancer in Nigeria,” is a Phase II clinical trial. During the ...